Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 d
- This topic has 0 replies, 1 voice, and was last updated 5 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
https://www.ncbi.nlm.nih.gov/pubmed/30518618
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.